Table 3 Lesions at baselinea
Lesion Location | nab-Paclitaxel 100 mg/m2 | nab-Paclitaxel 125 mg/m2 | All dose levels | ||
|---|---|---|---|---|---|
(n = 13) | (n = 38) | (n = 51) | Baseline SUVmax | ||
n (%) | n (%) | n (%) | Mean (St Dev) | Median | |
Pancreas | 11 (85) | 32 (84) | 43 (84) | 6.9 (3.6) | 6.4 |
Liver | 8 (62) | 29 (76) | 37 (73) | 7.6 (3.4) | 6.6 |
Peritoneum | 4 (31) | 24 (63) | 28 (55) | 5.9 (3.9) | 5.3 |
Mediastinal nodes | 3 (23) | 15 (39) | 18 (35) | 4.5 (2.9) | 4.0 |
Lung | 3 (23) | 11 (29) | 14 (27) | 2.6 (3.0) | 2.1 |
Pelvic nodes | 2 (15) | 7 (18) | 9 (18) | 6.8 (2.7) | 7.6 |
Hilar nodes | 2 (15) | 7 (18) | 9 (18) | 3.8 (1.8) | 4.1 |
Neck nodes | 1 (8) | 5 (13) | 6 (12) | 6.7 (4.8) | 5.1 |
Omentum/mesentery | 1 (8) | 5 (13) | 6 (12) | 6.8 (2.2) | 6.6 |
Pleura | 4 (31) | 2 (5) | 6 (12) | 2.8 (2.0) | 1.8 |
Bone | 1 (8) | 2 (5) | 3 (6) | 5.0 (1.4) | 4.2 |
Adrenal glands | 0 | 3 (8) | 3 (6) | 2.7 (1.4) | 2.1 |
Spleen | 0 | 2 (5) | 2 (4) | 3.1 (0.3) | 3.1 |
Skin | 2 (15) | 0 | 2 (4) | 5.9 (1.8) | 5.9 |
Muscle | 0 | 2 (5) | 2 (4) | 5.3 (1.1) | 5.3 |
Other | 0 | 0 | 0 | Not Applicable | |
Brain | 0 | 0 | 0 | Not Applicable | |
Kidneys | 0 | 0 | 0 | Not Applicable | |